Whether it's corporate growth, product upgrades, or meeting diverse consumer needs, continuous scientific research is the driving force behind it all.

 

After completing "Data Proves It! GanoHerb Leads the Industry in Reishi Research" based on two recent journal articles analyzing the trends in reishi research over the past two decades, I was curious about the specific scientific research conducted by GanoHerb. As a result, I conducted a comprehensive search using China National Knowledge Infrastructure (CNKI) and PubMed to identify research papers on reishi published by Fujian Xianzhilou Biological Science and Technology Co., Ltd. and the National R&D Sub-Center for Edible Fungi Processing Technology.

 

The results showed that GanoHerb's earliest Chinese-language research paper on reishi was "Analysis of Fatty Acid Components in Reishi Spore Oil," published in June 2005 in the journal Mycological Research. The most recent one is "GanoExtra Enhances the Efficacy and Reduces the Toxicity of Cyclophosphamide in Inhibiting Lung Metastasis of Mouse Breast Cancer," published in June 2024 in the Chinese Pharmacological Bulletin.

 

In terms of English-language publications on reishi research, GanoHerb's earliest study was "Development of Reishi Polysaccharide Injection," co-authored with Fujian Agriculture and Forestry University and the Molecular Characterization of Foodborne Pathogens Research Unit, USDA ARS, and published in International Journal of Medicinal Mushrooms in May 2014. The most recent study, "Ganoderma triterpene complex scavenges doxorubicin-induced senescent liver cancer cells," was co-authored with the Key Laboratory of Natural Product Pharmacology, Fujian Medical University, and published in Frontiers in Pharmacology in September 2024.

 

From the publication of its first research paper in 2005 to November 27, 2024 when this article was written, GanoHerb has published at least 65 Chinese and 15 English research papers on reishi, spanning nearly 20 years. These studies cover a wide range of topics, including cultivation techniques, production processes, quality control, authentication and traceability, safety and toxicology analysis, component analysis, pharmacological activity, and health benefits. Some of these studies were conducted independently by GanoHerb, while others were carried out in collaboration with other institutions. The following is a categorized summary of these research findings, including the journals in which they were published and the collaborating institutions.

 

Component Analysis

 

Spore Oil Component Analysis

 

1. Analysis of Fatty Acid Components in Reishi Spore Oil. Mycological Research, Issue 2, 2005.

 

2. Development and Validation of a High-Performance Liquid Chromatography Method for the Determination of Ergosterol in Ganoderma lucidum Spore Oil and Lycopene Complex Preparations. Edible Fungi of China, Issue 4, 2023.

 

Spore Powder Component Analysis

 

3. Determination of Adenosine Content in Sporoderm-Broken Ganoderma Lucidum Spore Powder by HPLC-PDA. Strait Pharmaceutical Journal, Issue 11, 2009. In collaboration with Fuzhou Pulmonary Hospital. 

 

4. Study on the Determination of Polysaccharide Content in Sporoderm-Broken Ganoderma Lucidum Spore Powder by Anthrone-Sulfuric Acid Method. Strait Pharmaceutical Journal, Issue 7, 2009.  

 

5. Differences in Active Ingredients of Ganoderma Lucidum Spores Before and After Sporoderm Breaking in a Simulated Human Digestive Environment. Edible Fungi, Issue 4, 2013. 

 

Fruiting Body Component Analysis

 

6. Determination of Ganoderic Acid A in Ganoderma lucidum Fruiting Body by Reversed-Phase High Performance Liquid Chromatography. Fujian Medical Journal, Issue 3, 2011. 

 

7. A Discussion on the Determination of Total Triterpenoids in Ganoderma lucidum Using Ultraviolet-Visible Spectroscopy. China Licensed Pharmacist, Issue 4, 2011. 

 

8. Determination of Nine Triterpenic Acids in Ganoderma Samples from Different Origins by HPLC. China Journal of Chinese Materia Medica, Issue 23, 2012. In collaboration with the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, and the Beijing Institute for Food and Drug Control.

 

9. Determination of Triterpenic Acids and Polysaccharides Content in Ganoderma lucidum Fruiting Bodies at Different Growth Stages. Edible and Medicinal Mushrooms, Issue 1, 2016. In collaboration with the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College.

 

10. Quantitative Analysis of Three Neutral Triterpenes and Ergosterol in Ganoderma lucidum Extract. Drug Evaluation Research, Issue 11, 2023. In collaboration with Fujian University of Traditional Chinese Medicine.

 

11. Study on the Characteristic Fingerprint Profile of Ultrafine Ganoderma Powder by High Performance Liquid Chromatography. China Pharmaceuticals,  Issue 18, 2022.

 

12. Study on the Chemical Constituents of Ganoderma duropora. Mycosystema, Issue 3, 2009. In collaboration with the Key Laboratory of the Ministry of Education for the Material Basis and Resource Utilization of Traditional Chinese Medicinal Herbs, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College.

 

13. Triterpenoids from Ganoderma theaecolum. China Journal of Chinese Materia Medica, Issue 6, 2016. In collaboration with the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College.

 

14. Study on the Chemical Changes of Quercus acutissima by Ganoderma lucidum Cultivation After Different Years Using FTIR Analysis. Spectrochimica Acta Part A: Molecular Spectroscopy, Volume 266, 2022. In collaboration with the Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical Sciences, and the Department of Phytochemistry, Herbal Medicine Research Center (HMRC), Institute for Medical Research (IMR), Malaysia.

 

Product Component Analysis

 

15. Determination of Adenosine Content in Different Series of Ganoderma Products by HPLC-PDA Method. Strait Journal of Preventive Medicine, Issue 3, 2009. In collaboration with the Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University.

 

16. Determination of Polysaccharides in GanoExtra Capsules. Northwest Pharmaceutical Journal, Issue 4, 2009. In collaboration with the School of Pharmacy, Fujian Medical University.

 

17. Study on the Determination of Crude Polysaccharide Content in Ganoderma Coffee by Enzymatic Method. Food Industry, Issue 10, 2015.

 

Literature review

 

18. Progress in Research on Triterpenoids from Ganoderma lucidum. China Journal of Chinese Materia Medica, Issue 2, 2012. In collaboration with the State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College.

 

19. Research Progress on Triterpenoids in Ganoderma lucidum. Chinese Traditional and Herbal Drugs, Issue 12, 2015. In collaboration with the School of Bioengineering, Jilin Engineering Vocational College, and the Institute of Medicinal Plant Development, Peking Union Medical College, Chinese Academy of Medical Sciences.

 

Production Process

 

Rough Processing

 

20. The Impact of Ultrafine Pulverization on Polysaccharides and Triterpenoids in Ganoderma lucidum. China Licensed Pharmacist, Issue 8, 2015. In collaboration with the School of Chemistry, Fuzhou University.

 

21. Study on the Preparation Process of Ganoderma Slices. Strait Pharmaceutical Journal, Issue 2, 2019.

 

Deep Processing

 

22. Study on the Process of Supercritical CO2 Extraction of Ganoderma lucidum Spore Oil. Edible Fungi of China, Issue 6, 2009. In collaboration with Fujian Agriculture and Forestry University.

 

23. Study on the High-Pressure Supercritical CO2 Extraction of Triterpenoids and Sterols from Ganoderma lucidum. Edible Fungi of China, Issue 5, 2018.

 

24. Study on the Subcritical Water Extraction Process of Acidic and Neutral Triterpenoids from Ganoderma. Edible and Medicinal Mushrooms, Issue 4, 2021.

 

25. Optimization of the High-Temperature and High-Pressure Water Extraction Process for Ganoderma β-Glucan. Edible Fungi, Issue 1, 2022.

 

26. Study on the Extraction and Membrane Separation Process of Defatted Ganoderma Spore Polysaccharides. Acta Edulis Fungi, Issue 1, 2015.

 

27. Study on the Extraction and Industrial Separation of Defatted Ganoderma Spore Polysaccharides. Edible Fungi of China, Issue 2, 2015.

 

28. Optimization of the Extraction Process of Crude Polysaccharides from Ganoderma Green Tea and Determination of Its Content. Strait Pharmaceutical Journal, Issue 7, 2013.

 

29. Optimization of the Extraction Process of Total Saponins from Ginseng Ganoderma Tea and Determination of Its Content. Strait Pharmaceutical Journal, Issue 4, 2021.

 

30. Development of Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Higher Basidiomycetes) Polysaccharides Injection Formulation. International Journal of Medicinal Mushrooms, Issue 5, 2014. In collaboration with the College of Life Sciences, College of Food Science, and Fungal Research Center, Fujian Agriculture and Forestry University; Molecular Characterization of Foodborne Pathogens Research Unit, Agricultural Research Service, U.S. Department of Agriculture; Beijing Sailin Tai Pharmaceutical Technology Co., Ltd.

 

Identification, Quality Control, and Traceability

 

Identification of authenticity

 

31. Study on the Identification of Ganoderma lucidum Spore Oil Based on Near-Infrared Spectroscopy and Chemometrics. Infrared, Issue 12, 2012. In collaboration with the Key Laboratory of the Ministry of Education for Food Safety Analysis and Testing (Fuzhou University), and Fujian Entry-Exit Inspection and Quarantine Bureau.

 

32. Study on the Rapid Detection Method for Adulteration of Ganoderma lucidum Spore Oil with Other Common Edible Oils. Edible and Medicinal Mushrooms, Issue 1, 2022. In collaboration with the Beijing Key Laboratory of Crystalline Drug Research.

 

Quality Control and Traceability

 

33. Construction of Quality Control and Traceability System for Exported Ganoderma Products. Edible and Medicinal Mushrooms, Issue 6, 2015.

 

34. Study on Quality Control of Multiple Triterpenoids in Ganoderma Extract.
Strait Pharmaceutical Journal, Issue 6, 2020.

 

35. Determination of Ganoderenic Acid D Content in Ganoderma from Fujian and Its Application in Origin Traceability by UPLC-QqQ-MS. Journal of North Pharmacy, Issue 11, 2022. In collaboration with the School of Pharmacy, Fujian University of Traditional Chinese Medicine; the Science and Technology Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine.

 

36. Identification of Ganoderma from Fujian by High-Performance Thin-Layer Chromatography and Its Application in Traceability. Journal of Pharmaceutical Research, Issue 2, 2023. In collaboration with the School of Pharmacy, Fujian University of Traditional Chinese Medicine; the Biomedical R&D Center, Fujian University of Traditional Chinese Medicine; the College of Electrical Engineering and Automation, Fuzhou University.

 

37. Determination of Six Major Triterpenoid Contents in Ganoderma lucidum from Fujian and Their Application in Traceability. Heilongjiang Medicine Journal, Issue 1, 2023. In collaboration with the School of Pharmacy, Fujian University of Traditional Chinese Medicine; the Science and Technology Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine.

 

38.  Quality Control of Ganoderma lucidum by Using C, H, O, and N Stable Isotopes and C and N Contents for Geographical Traceability. Frontiers in Plant Science, Issue 11, 2023. In collaboration with the School of Pharmacy, Fujian University of Traditional Chinese Medicine; the Science and Technology Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine; and the Department of Pharmacology, Universiti Sains Malaysia.

 

Safety and toxicological analysis

 

39. Study on the acute toxicity and mutagenicity of Ganoderma lucidum spore oil. Central South Pharmacy, Issue 4, 2006. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

40. Experimental study on the acute and genetic toxicity of Ganoderma lucidum spore powder capsules. Tianjin Pharmacy, Issue 2, 2007. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

41. Study on the subacute toxicity of Ganoderma and Cordyceps mixture. Preventive Medicine Tribune, Issue 8, 2009. In collaboration with the Fujian Provincial Center for Disease Control and Prevention and the Fujian Provincial Center for Quality Testing of Laboratory Animals.

 

42. Study on the toxicological safety of Ganoderma granules. Strait Pharmaceutical Journal, Issue 12, 2016. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

Pharmacological activities related to anti-tumor effects

 

Anti-cancer ingredients

 

43. Study on the in vivo and in vitro Anti-tumor Effects of Ganoderma lucidum Triterpene Components GLA. Journal of Fujian Medical University, Issue 6, 2010. In collaboration with the School of Pharmacy, Fujian Medical University and the Institute of New Drug Research, Fujian Medical University.

 

44. The Chemical Constituents and Anti-tumor Activity of Ganoderma lucidum Fruiting Bodies. Chinese Journal of Hospital Pharmacy, Issue 21, 2015. In collaboration with the School of Pharmacy, Fujian Medical University；Fujian Provincial Key Laboratory of Natural Drug Pharmacology, Fujian Medical University；the Department of Molecular and Cellular Biology, University of Arizona, USA.

 

45. Antitumor effects and mechanisms of Ganoderma extracts and spores oil. Oncology Letters, Issue 5, 2016. In collaboration with the Fujian Provincial Key Laboratory of Natural Drug Pharmacology, School of Pharmacy, Fujian Medical University, and the Laboratory of Systems Biology, Department of Molecular and Cellular Biology, University of Arizona, USA.

 

46. Cytotoxic lanostane-type triterpenes from the fruiting bodies of Ganoderma lucidum. Natural Product Research, Issue 18, 2023. In collaboration with Fujian Provincial Key Laboratory of Natural Drug Pharmacology, School of Pharmacy, Fujian Medical University; Department of Pharmacy, The Second Hospital of Fuzhou

 

Anticancer mechanism

 

47. Study on the Anti-tumor Effects of Ganoderma lucidum and its Spore Extracts and Their Effects on DNA Topoisomerases. Pharmacology and Clinics of Chinese Materia Medica, Issue 2, 2008. In collaboration with the Institute of Clinical Pharmacology, School of Pharmacy, Fujian Medical University.

 

48. Elimination of quiescent slow-cycling cells via reducing quiescence depth by natural compounds purified from Ganoderma lucidum. Oncotarget, Issue 8, 2017. In collaboration with the Department of Molecular and Cellular Biology, University of Arizona, the University of Arizona Cancer Center, Jiangsu Academy of Agricultural Sciences, and Fujian Provincial Key Laboratory of Pharmacology of Natural Products, School of Pharmacy, Fujian Medical University.

 

49. High-pressure supercritical CO2 extracts of Ganoderma lucidum fruiting body and their anti-hepatoma effect associated with the Ras/Raf/MEK/ERK signaling pathway. Frontiers in Pharmacology, Issue 11, 2020. In collaboration with Fujian Provincial Key Laboratory of Pharmacology of Natural Products, School of Pharmacy, Fujian Medical University.

 

50. Sterols and triterpenoids from Ganoderma lucidum and their reversal activities of tumor multidrug resistance. Natural Product Research, Issue 5, 2022. In collaboration with Fujian Provincial Key Laboratory of Pharmacology of Natural Products, School of Pharmacy, Fujian Medical University, the Department of Pharmacy, Shanghai Skin Disease Hospital, and the School of Basic Medicine, Fujian Medical University.

 

51. Lucialdehyde B suppresses proliferation and induces mitochondria-dependent apoptosis in nasopharyngeal carcinoma CNE2 cells. Pharmaceutical Biology, Issue 1, 2023. In collaboration with Fujian Provincial Key Laboratory of Pharmacology of Natural Products, School of Pharmacy, Fujian Medical University, the Department of Pharmacy, Fujian Provincial Clinical Medical College, Fujian Medical University, and the Department of Pharmacy, The Second Affiliated Hospital of Xiamen Medical College.

 

52. Ganoderma lucidum extract promotes tumor cell pyroptosis and inhibits metastasis in breast cancer. Food and Chemical Toxicology, Issue 4, 2023. In collaboration with the Marine Drug R&D Center, Minjiang University, School of Basic Medical Sciences, Gannan Medical University, the School of Pharmacy, Fujian University of Traditional Chinese Medicine, and the Translational Research Center in Onco-Hematology, Faculty of Medicine, University of Geneva, Switzerland.

 

Adjuvant therapy

 

53. Therapeutic Effect of Tumor Heat Shock Protein 70 Combined with Ganoderma lucidum Spore Powder on Tumor-Bearing Mice. Jiangxi Medical Journal, Issue 9, 2011. In collaboration with the School of Medicine, Ningbo University, Zhejiang Province; the Department of Surgical Oncology, The Second Hospital of Ningbo, Zhejiang Province.

 

54. Regulatory Effects of Ganoderma Extracts in Cancer Immunotherapy. Chinese Journal of General Practice, Issue 3, 2014. In collaboration with the Department of General Surgery, Ningbo Beilun District People's Hospital, Zhejiang Province; the Department of Surgical Oncology, The Second Hospital of Ningbo, Zhejiang Province.

 

55. Ganoderma GanoExtra enhances the synergistic and detoxifying effects of cyclophosphamide in inhibiting lung metastasis of breast cancer in mice.  Chinese Pharmacological Bulletin, Issue 7, 2024. In collaboration with the School of Materials and Chemical Engineering, Minjiang University.

 

56. Ganoderma lucidum spore oil synergistically enhances the function of cyclophosphamide in the prevention of breast cancer metastasis. Journal of the Chinese Medical Association, Issue 3, 2024. In collaboration with the Biopharmaceutical Research Center of the School of Materials and Chemical Engineering, Minjiang University, the School of Chemistry, Fuzhou University, the School of Pharmacy, Fujian University of Traditional Chinese Medicine, and the Translational Research Center in Onco-Hematology, Faculty of Medicine, University of Geneva, Switzerland.

 

57. Senolytic effect of triterpenoid complex from Ganoderma lucidum on adriamycin-induced senescent human hepatocellular carcinoma cells model in vitro and in vivo. Frontiers in Pharmacology, Volume 15, 2024. In collaboration with Fujian Provincial Key Laboratory of Pharmacology of Natural Products, School of Pharmacy, Fujian Medical University.

 

Health benefits

 

Anti-radiation

 

58. Study on the Radioprotective Effects of Compound Ganoderma Powder in Mice. Central South Pharmacy, Issue 1, 2007. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

Immunomodulation and inflammation regulation

 

59. Effects of Ganoderma Granules on Immune Function in Mice. Strait Pharmaceutical Journal, Issue 1, 2017. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

60. Study on the Effects of Ganoderma Coffee on Immune Function in Mice.

Food Science and Technology, Issue 3, 2017.

 

61. Ganoderma lucidum polysaccharides ameliorate lipopolysaccharide induced acute pneumonia via inhibiting NRP1 mediated inflammation. Pharmaceutical Biology, Issue 1, 2022. In collaboration with the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences.

 

Gastric protection

 

62. Protective Effects of Ganoderma lucidum Spore Oil, Sporoderm-Broken Ganoderma lucidum Spore Powder, and Ganoderma lucidum Spore Extract on Acute Gastric Ulcer in Mice. Drug Evaluation Research, Issue 2, 2022. In collaboration with the School of Pharmacy, Fujian University of Traditional Chinese Medicine.

 

Hepatic protection

 

63. Study on the Protective Effects of Ganoderma lucidum Spore Oil on Chemically Induced Liver Injury. Guangxi Journal of Traditional Chinese Medicine, Issue 3, 2006. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

64. Protective Effects of a Compound Preparation of Ganoderma lucidum Spore Oil Extract on Alcoholic Liver Injury. Edible Fungi of China, Issue 6, 2016. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

65. Experimental Study on the Prevention and Treatment of Chemically Induced Liver Injury with Compound Ganoderma Preparations. Journal of Beijing University of Traditional Chinese Medicine (Clinical Chinese Medicine), Issue 6, 2006. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

66. Study on the Protective Effects of Whole Ganoderma lucidum Spore Powder on Chemically Induced Liver Injury. Practical Preventive Medicine, Issue 3, 2007. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

67. Study on the Protective Effects of Ganoderma lucidum Triterpenoids on Chemically Induced Liver Injury. Journal of Preventive Medicine Information, Issue 11, 2010. In collaboration with the Fujian Provincial Center for Disease Control and Prevention and Fujian College of Traditional Chinese Medicine.

 

68. Triterpenes from antler-shaped fruiting body of Ganoderma lucidum and their hepatoprotective activities. Phytochemistry, August 2024. In collaboration with the State Key Laboratory of Active Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences.

 

Anti-fatigue and sleep aid

 

69. Study on the Alleviation of Physical Fatigue by Compound Cordyceps and Ganoderma lucidum Preparations. Preventive Medicine Tribune, Issue 10, 2010. In collaboration with the Fujian Provincial Center for Disease Control and Prevention, and the Teaching Base of Fujian Medical University.

 

70. Experimental Study on the Improvement of Sleep in Mice by Compound Ganoderma lucidum Preparations. Strait Pharmaceutical Journal, Issue 5, 2011. In collaboration with the Fujian Provincial Center for Disease Control and Prevention.

 

71. The anti-fatigue and sleep-aiding effects vary significantly among different recipes containing Ganoderma lucidum extracts. Heliyon, Issue 10, 2024. In collaboration with the State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, the College of Life Sciences, Fujian Agriculture and Forestry University, the School of Integrated Traditional Chinese and Western Medicine, Fujian University of Traditional Chinese Medicine, the College of Biological Science and Engineering, Fuzhou University, and the University of Chinese Academy of Sciences (UCAS).

 

Cultivation techniques

 

Raw material quality control

 

72. Organic Cultivation Techniques of Ganoderma. Strait Pharmaceutical Journal, Issue 1, 2010. In collaboration with the Mycological Research Center, Fujian Agriculture and Forestry University

 

73. Screening of the Dominant Strain in Ganoderma lucidum Cultivated with Loquat Branch Cuttings. Modern Agricultural Science and Technology, Issue 24, 2013. In collaboration with the Fujian Vocational College of Agriculture.

 

74. Effects of Loquat-Branch Dust Substitution on Ganoderma lucidum Cultivation in Its Main Active Components. Journal of Chinese Medicinal Materials, Issue 12, 2015. In collaboration with the Fujian Vocational College of Agriculture.

 

75. Effects of Solid-State Fermentation of Ganoderma lucidum on the Main Active Components in Leaves of Eriobotrya japonica. Natural Product Research and Development, Issue 2, 2016. In collaboration with the Fujian Vocational College of Agriculture.

 

76. Effect of Loquat Branch Cutting Substitute Cultivation on Different Strains of Ganoderma lucidum. Northern Horticulture, Issue 14, 2017. In collaboration with the Fujian Vocational College of Agriculture.

 

77. Analysis of the Effects of Different Loquat Branch Cutting Formulations on the Cultivation Characteristics and Quality of Ganoderma lucidum. AGRICULTURE AND TECHNOLOGY, Issue 3, 2022. In collaboration with the Fujian Vocational College of Agriculture.

 

Resource development

 

78. Exploitation and utilization of wild Zhizi resource in Fujian Ⅰ. Ganoderma duropora (Sect.Phaeonema). Journal of Fujian Agriculture and Forestry University (Natural Science Edition), Issue 3, 2006. In collaboration with the Fujian Academy of Agricultural Sciences, the Department of Pharmacy, Fujian University of Traditional Chinese Medicine, and the Edible Mushroom Station of Wuping County, Fujian Province.

 

79. Exploitation and Utilization of Wild Zhizi Resources (Sect. Phaeonema of Ganoderma) in Fujian (Ⅱ). G. Sinense "Minzi 96". Mycological Research, Issue 4, 2006. In collaboration with the Fujian Academy of Agricultural Sciences, the Department of Pharmacy, Fujian University of Traditional Chinese Medicine, and the Edible Mushroom Development Company of Qidong City, Jiangsu Province.

 

80. Identification and liquid fermentation characteristics of a wild Ganoderma sp. Strain. Acta Agriculturae Shanghai, Issue 6, 2023. In collaboration with the Institute of Edible Fungi,Shanghai Academy of Agricultural Science.

 

 

 

After reviewing the aforementioned scientific literature published in academic journals, I was struck by the sheer number of details that require attention and research to cultivate and produce high-quality Ganoderma.

 

The aforementioned research, covering various aspects such as Ganoderma cultivation techniques, production processes, quality control, identification and traceability, safety and toxicity analysis, component analysis, pharmacological activity, and health benefits, although representing only a small portion of GanoHerb's investment in Ganoderma research, specifically and microcosmically reveals the origins of GanoHerb's establishment of the entire Ganoderma industry chain. It also illustrates that "GanoHerb Ganoderma" not only benefits from the nurturing of good mountains and good water but also possesses the inherent qualities of scientific and technological innovation and the strength for product upgrades.

 

In this mixed Ganoderma market, with GanoHerb focusing on scientific research to ensure the safety and quality of Ganoderma, continuously creating science-based and health-promoting Ganoderma products for the world, it is indeed a great reassurance and blessing for consumers.

 

 

END

 

★ This article is exclusively authorized by the author for publication, and its ownership belongs to GanoHerb.

★ The above works cannot be reproduced, excerpted or used in other ways without the authorization of GanoHerb.

★ Those who have been authorized to use the works should use them within the scope of authorization and indicate the source: GanoHerb.

★ GanoHerb will pursue legal responsibilities against those who violate the above statement.

★ The original manuscript of this article was authored in Chinese by Wu Tingyao and subsequently translated into English by Alfred Liu. In the event of any inconsistencies between the English translation and the original Chinese text, the latter shall take precedence. For any queries, pls reach out to the original author, Ms. Wu Tingyao.